S
Szilard Voros
Researcher at Stony Brook University
Publications - 119
Citations - 3527
Szilard Voros is an academic researcher from Stony Brook University. The author has contributed to research in topics: Coronary artery disease & Intravascular ultrasound. The author has an hindex of 27, co-authored 117 publications receiving 3132 citations. Previous affiliations of Szilard Voros include University of Alabama at Birmingham & Semmelweis University.
Papers
More filters
Journal ArticleDOI
Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis.
Szilard Voros,Sarah Rinehart,Zhen Qian,Parag H. Joshi,Gustavo Vazquez,Collin Fischer,Pallavi Belur,Edward Hulten,Todd C. Villines +8 more
TL;DR: Emerging data show that coronary CTA-based semiquantitative plaque characterization and quantification are sufficiently reproducible for clinical purposes, and fully quantitative approaches may be appropriate for use in clinical trials.
Journal ArticleDOI
Comprehensive plaque assessment by coronary CT angiography
TL;DR: The combination of morphologic and functional characteristics of coronary plaques might enable noninvasive detection of vulnerable plaques in the future to reduce mortality and morbidity of coronary heart disease.
Journal ArticleDOI
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial
Alexandra J. Lansky,Joachim Schofer,Didier Tchetche,Pieter R. Stella,Cody Pietras,Helen Parise,Kevin J. Abrams,John K. Forrest,Michael W. Cleman,Jochen Reinöhl,Thomas Cuisset,Daniel J. Blackman,Gil Bolotin,Stefan G. Spitzer,Utz Kappert,Martine Gilard,Thomas Modine,David Hildick-Smith,M Haude,Pauliina Margolis,Adam M. Brickman,Szilard Voros,Andreas Baumbach +22 more
TL;DR: In this exploratory study, subjects undergoing protected TAVI had more freedom from ischaemic brain lesions, fewer neurologic deficits, and improved cognitive function in some domains at discharge and 30 days compared with controls.
Journal ArticleDOI
Prospective Validation of Standardized, 3-Dimensional, Quantitative Coronary Computed Tomographic Plaque Measurements Using Radiofrequency Backscatter Intravascular Ultrasound as Reference Standard in Intermediate Coronary Arterial Lesions: Results From the ATLANTA (Assessment of Tissue Characteristics, Lesion Morphology, and Hemodynamics by Angiography With Fractional Flow Reserve, Intravascular Ultrasound and Virtual Histology, and Noninvasive Computed Tomography in Atherosclerotic Plaques) I Study
Szilard Voros,Sarah Rinehart,Zhen Qian,Gustavo Vazquez,Hunt Anderson,Laura Murrieta,Charles Wilmer,Harold Carlson,Kenneth Taylor,William Ballard,Dimitri Karmpaliotis,Anna Kalynych,Charles R. Brown +12 more
TL;DR: This is the first validation that standardized, 3-dimensional, quantitative measurements of coronary plaque correlate with IVUS/VH, and mean differences are small, whereas limits of agreement are wide.
Journal ArticleDOI
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
Rory Hachamovitch,Benjamin Nutter,Mark A. Hlatky,Leslee J. Shaw,Michael L. Ridner,Sharmila Dorbala,Rob S. Beanlands,Benjamin J.W. Chow,Elizabeth Branscomb,Panithaya Chareonthaitawee,W. Guy Weigold,Szilard Voros,Suhny Abbara,Tsunehiro Yasuda,Jill E. Jacobs,John R. Lesser,Daniel S. Berman,Louise Thomson,Subha V. Raman,Gary V. Heller,Adam E. Schussheim,Richard C. Brunken,Kim A. Williams,Susan Farkas,Dominique Delbeke,Uwe Joseph Schoepf,Nathaniel Reichek,Stuart Rabinowitz,Steven R. Sigman,Randall Patterson,Carolyn R. Corn,Richard D. White,Ella A. Kazerooni,James R. Corbett,Sabahat Bokhari,Josef Machac,Erminia M. Guarneri,Salvador Borges-Neto,John W. Millstine,James H. Caldwell,James A. Arrighi,Udo Hoffmann,Matthew J. Budoff,Joao A.C. Lima,James R. Johnson,Barbara Johnson,Mariya Gaber,Julie A. Williams,Courtney Foster,Jon Hainer,Marcelo F. Di Carli +50 more
TL;DR: Overall, noninvasive testing had only a modest impact on clinical management of patients referred for clinical testing and post-imaging use of cardiac catheterization and medical therapy increased in proportion to the degree of abnormality findings, suggesting possible undertreatment of higher risk patients.